1-4-{[6-Amino-5-(4-Phenoxy-Phenyl)-Pyrimidin-4-Ylamino]-Methyl}-4-Fluoro-Piperidin-1-Yl)-Propenone

2 trials

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

0 Recruiting

2 Completed trials

1 Sponsors

10 Countries

Phase II

Phase I (FiH)

Phase II: 1 Phase I (FiH): 1

Oversight events:

1 unexpected event across 1 trial

View oversight register →

Indications tested

B-cell small lymphocytic lymphoma 1 Indolent systemic mastocytosis 1

Sponsors using this IMP

Telios Pharma Inc. 2

All trials

2 total

A Study of TL-895 in Myelofibrosis, Indolent Systemic Mastocytosis, Monoclonal Mast Cell Activation Syndrome, or Non-Monoclonal Mast Cell Ac… Ended

2024-514467-26-00 Phase II 9 countries Telios Pharma Inc.
Phase I/II, First in Human, Dose Escalation Trial of TL-895 Monotherapy in Subjects with Relapsed/Refractory B-Cell Malignancies and Expansi… Ended

2024-516691-14-00 Phase I (FiH) 2 countries Telios Pharma Inc.

Showing 1–2 of 2 trials

← All drugs A–Z